Selective Inhibition of Leukocyte Adherence in Women with Breast Cancer Using a Variety of Tissue Extracts
- 1 January 1978
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 35 (6) , 242-245
- https://doi.org/10.1159/000225297
Abstract
Leukocyte adherence inhibition (LAI) tests tor the assessment of tumor immunity in vitro have been based on the assumption that the adherence of the leukocytes is inhibited by specific interaction with an antigenic tumor extract. However, loss of leukocyte adherence could depend on several non-immunological factors including disease state of the leukocyte donor and the presence of a variety of agents, proteins or tissue extracts. We have studied LAI, therefore, using different species and concentrations of serum protein or tissue extracts. Our results show that leukocytes from patients with a variety of diseases adhere to glass in a rather consistent fashion. High concentrations of serum protein or tissue extract inhibited leukocyte adherence. 39 breast cancer patients and 38 female controls were studied with a total of 23 solubilized extracts from breast carcinoma, other tumor and non-tumor tissues. Breast cancer patients showed selective LAI in the presence of 200 μg per test tube of several breast carcinoma extracts.Keywords
This publication has 8 references indexed in Scilit:
- Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patientsCancer, 1977
- An overview: Antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibitionCancer, 1977
- A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancerInternational Journal of Cancer, 1977
- Granulocyte Adherence Changes Induced by Hemodialysis, Endotoxin, Epinephrine, and GlucocorticoidsAnnals of Internal Medicine, 1977
- Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assayInternational Journal of Cancer, 1976
- Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti‐tumour immunity. III. “Blockade” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patientsInternational Journal of Cancer, 1976
- Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibodyInternational Journal of Cancer, 1976
- Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. I. Monocyte is the reactive cellInternational Journal of Cancer, 1976